sr 48692 has been researched along with verapamil hydrochloride in 1 studies
Studies (sr 48692) | Trials (sr 48692) | Recent Studies (post-2010) (sr 48692) | Studies (verapamil hydrochloride) | Trials (verapamil hydrochloride) | Recent Studies (post-2010) (verapamil hydrochloride) |
---|---|---|---|---|---|
203 | 3 | 36 | 38 | 0 | 22 |
Protein | Taxonomy | sr 48692 (IC50) | verapamil hydrochloride (IC50) |
---|---|---|---|
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.38 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
1 other study(ies) available for sr 48692 and verapamil hydrochloride
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |